Just Two Days to Save on Best Practices in Licensing!

Having trouble viewing this email? Click here

	Attend this two-day interactive course and gain core knowledge, useful methodologies and tools to leverage immediately in your organization.
	In this interactive, two day program, you'll hear first-hand tales from the trenches and on high as top industry experts shed light on best practices for structuring and negotiating transactions. Learn from their experiences and leave armed with the key components necessary to successfully close transactions you set your sights upon. The high teacher-student ratio optimizes one-on-one interactions with the experts and your peers, so you get the most out of the program. Master fundamentals of patents, copyrights, trademarks and trade secrets Establish material terms of a license agreement Structure critical financial terms and considerations Leverage arbitration and alternative dispute resolution Understand key legal issues and trends to be more effective in your transactions Access our website for detailed information. Register by October 30 to SAVE!
	Learn From the Best   LES has been teaching the Best Practices Course for over 30 years. The course faculty is comprised of leading industry experts who draw on their extensive real-world experiences. Featuring Experts from: Baker Hughes, Inc BMC Software Exxon Mobil Microsoft Corporation Stanford University Capstone Advisory Group Finnegan, Henderson, Farabow, Garrett & Dunner, LLP Seyfarth Shaw LLP Sterne, Kessler, Goldstein & Fox 284 Partners, LLC Read our faculty bios     Who Should Attend   This course is designed for business development, legal, and technical professionals new to day-to-day management responsibilities of monetizing intellectual property assets as well as those with a few years of IP experience seeking to enhance the breadth of their transaction skills. Past attendees have included professionals from Abbott Laboratories, Becton Dickinson, Northrop Grumman, Kauffman Foundation, Beckman Coulter, Pfizer, Amylin Pharmaceuticals, STMicroelectronics, SRI International, Johns Hopkins, Intellectual Ventures, Boeing, Raytheon, Procter & Gamble, Tessera, University of Cincinnati, Kellog Company, John Deere, Wellman, Philip Morris, Roche, Yale School of Medicine, Athena Diagnostics Cleveland Clinic Innovations, IBM,  Merck, Syngenta, and more. Location Course PricewaterhouseCoopers LLP 1201 Louisiana Street Suite 2900 Houston, Texas 77002 Reception The Grove Houston 1611 Lamar Houston, Texas 77010     Registration Fees By October 30, 2012 $995       Members $1,295   Non-Members October 31 and Later $1,195   Members $1,495   Non-Members     Co-Hosted by:     Earn Your Continuing Education Credits Attendees can earn up to 13.5 CLE (including ethics), 13.5 CLP, and 16 CPE credit hours.     Thank you to our Sponsors
© 2012 Licensing Executives Society (U.S.A. and Canada), Inc. All rights reserved.

Forward email This email was sent to seth.t.chase@gmail.com by mail@les.org |   Update Profile/Email Address | Instant removal with SafeUnsubscribe™ | Privacy Policy. LES (USA & Canada) | 1800 Diagonal Road | Suite 280 | Alexandria | VA | 22314

One Week to Save on Best Practices in Licensing!

Having trouble viewing this email? Click here

	Attend this two-day interactive course and gain core knowledge, useful methodologies and tools to leverage immediately in your organization.
	In this interactive, two day program, you'll hear first-hand tales from the trenches and on high as top industry experts shed light on best practices for structuring and negotiating transactions. Learn from their experiences and leave armed with the key components necessary to successfully close transactions you set your sights upon. The high teacher-student ratio optimizes one-on-one interactions with the experts and your peers, so you get the most out of the program. Master fundamentals of patents, copyrights, trademarks and trade secrets Establish material terms of a license agreement Structure critical financial terms and considerations Leverage arbitration and alternative dispute resolution Understand key legal issues and trends to be more effective in your transactions Access our website for detailed information. Register by October 30 to SAVE!
	Learn From the Best   LES has been teaching the Best Practices Course for over 30 years. The course faculty is comprised of leading industry experts who draw on their extensive real-world experiences. Featuring Experts from: Baker Hughes, Inc BMC Software Exxon Mobil Microsoft Corporation Stanford University Capstone Advisory Group Finnegan, Henderson, Farabow, Garrett & Dunner, LLP Seyfarth Shaw LLP Sterne, Kessler, Goldstein & Fox 284 Partners, LLC Read our faculty bios     Who Should Attend   This course is designed for business development, legal, and technical professionals new to day-to-day management responsibilities of monetizing intellectual property assets as well as those with a few years of IP experience seeking to enhance the breadth of their transaction skills. Past attendees have included professionals from Abbott Laboratories, Becton Dickinson, Northrop Grumman, Kauffman Foundation, Beckman Coulter, Pfizer, Amylin Pharmaceuticals, STMicroelectronics, SRI International, Johns Hopkins, Intellectual Ventures, Boeing, Raytheon, Procter & Gamble, Tessera, University of Cincinnati, Kellog Company, John Deere, Wellman, Philip Morris, Roche, Yale School of Medicine, Athena Diagnostics Cleveland Clinic Innovations, IBM,  Merck, Syngenta, and more. Location Course PricewaterhouseCoopers LLP 1201 Louisiana Street Suite 2900 Houston, Texas 77002 Reception The Grove Houston 1611 Lamar Houston, Texas 77010     Registration Fees By October 30, 2012 $995       Members $1,295   Non-Members October 31 and Later $1,195   Members $1,495   Non-Members     Co-Hosted by:     Earn Your Continuing Education Credits Attendees can earn up to 13.5 CLE (including ethics), 13.5 CLP, and 16 CPE credit hours.     Thank you to our Sponsors
© 2012 Licensing Executives Society (U.S.A. and Canada), Inc. All rights reserved.

Forward email This email was sent to seth.t.chase@gmail.com by mail@les.org |   Update Profile/Email Address | Instant removal with SafeUnsubscribe™ | Privacy Policy. LES (USA & Canada) | 1800 Diagonal Road | Suite 280 | Alexandria | VA | 22314

Oct 23 Meeting: Registration Closes at Noon Today!

Email not displaying correctly? View it in your browser. LES Boston Chapter Meeting DATE & TIME Tuesday, October 23, 2012 5:30 PM – 8:00 PM LOCATION AstraZeneca R&D Boston 35 Gatehouse Drive Waltham, MA 02451 (781) 839 – 4000 TITLE New Models for Deal Making in Pharma/Biotech MODERATOR Robert Ward, VP New Opportunities, Innovative Medicines Group, AstraZeneca PANELISTS Karen Gallant, VP of Strategic Partnering & Business Development, AstraZeneca Paulina Hill, Senior Associate, Polaris Venture Partners TBD, Biotech industry representative DESCRIPTION A steady shift has taken place in pharma/biotech deal making from outright product licensing to a company acquisition strategy based upon contingent payments.  For example, a 2012 M&A Study by SRS Life Sciences revealed that 83% (n=47) of private-target acquisitions involved earn-outs potentially worth >$7 billion.  On the surface, the deals appear more lucrative and the payouts occur in a shorter timeframe (< 4 years after acquisition, Source:SRS data).  However, with the advantages of these terms comes an increase in the overall risk due to the structure of the payments and a loss of developmental control.  SRS Life Sciences estimates that at launch, only 36% of milestone events have been achieved and only 30% of milestone payments have been paid.  In this type of evolving deal making environment, what are the key success factors for both sides to consider? Click here for for online registration and meeting information You are receiving this message because we believe you may be interested in the events and activities of the Licensing Executives Society. Our mailing address is: Licensing Executives Society 1800 Diagonal Road Suite 280 Alexandria, VA 22314 Copyright (C) 2012 Licensing Executives Society All rights reserved.

Sent to seth.t.chase@gmail.com — why did I get this? unsubscribe from this list | update subscription preferences Licensing Executives Society · 1800 Diagonal Road · Suite 280 · Alexandria, VA 22314

Oct 23 Meeting: New Models for Deal Making in Pharma/Biotech

Email not displaying correctly? View it in your browser. LES Boston Chapter Meeting DATE & TIME Tuesday, October 23, 2012 5:30 PM – 8:00 PM LOCATION AstraZeneca R&D Boston 35 Gatehouse Drive Waltham, MA 02451 (781) 839 – 4000 TITLE New Models for Deal Making in Pharma/Biotech MODERATOR Robert Ward, VP New Opportunities, Innovative Medicines Group, AstraZeneca PANELISTS Karen Gallant, VP of Strategic Partnering & Business Development, AstraZeneca Paulina Hill, Senior Associate, Polaris Venture Partners TBD, Biotech industry representative DESCRIPTION A steady shift has taken place in pharma/biotech deal making from outright product licensing to a company acquisition strategy based upon contingent payments.  For example, a 2012 M&A Study by SRS Life Sciences revealed that 83% (n=47) of private-target acquisitions involved earn-outs potentially worth >$7 billion.  On the surface, the deals appear more lucrative and the payouts occur in a shorter timeframe (< 4 years after acquisition, Source:SRS data).  However, with the advantages of these terms comes an increase in the overall risk due to the structure of the payments and a loss of developmental control.  SRS Life Sciences estimates that at launch, only 36% of milestone events have been achieved and only 30% of milestone payments have been paid.  In this type of evolving deal making environment, what are the key success factors for both sides to consider? Click here for for online registration and meeting information You are receiving this message because we believe you may be interested in the events and activities of the Licensing Executives Society. Our mailing address is: Licensing Executives Society 1800 Diagonal Road Suite 280 Alexandria, VA 22314 Copyright (C) 2012 Licensing Executives Society All rights reserved.

Sent to seth.t.chase@gmail.com — why did I get this? unsubscribe from this list | update subscription preferences Licensing Executives Society · 1800 Diagonal Road · Suite 280 · Alexandria, VA 22314

Oct 23 Meeting: New Models for Deal Making in Pharma/Biotech

Email not displaying correctly? View it in your browser. LES Boston Chapter Meeting DATE & TIME Tuesday, October 23, 2012 5:30 PM – 8:00 PM LOCATION AstraZeneca R&D Boston 35 Gatehouse Drive Waltham, MA 02451 (781) 839 – 4000 TITLE New Models for Deal Making in Pharma/Biotech MODERATOR Robert Ward, VP New Opportunities, Innovative Medicines Group, AstraZeneca PANELISTS Karen Gallant, VP of Strategic Partnering & Business Development, AstraZeneca Paulina Hill, Senior Associate, Polaris Venture Partners TBD, Biotech industry representative DESCRIPTION A steady shift has taken place in pharma/biotech deal making from outright product licensing to a company acquisition strategy based upon contingent payments.  For example, a 2012 M&A Study by SRS Life Sciences revealed that 83% (n=47) of private-target acquisitions involved earn-outs potentially worth >$7 billion.  On the surface, the deals appear more lucrative and the payouts occur in a shorter timeframe (< 4 years after acquisition, Source:SRS data).  However, with the advantages of these terms comes an increase in the overall risk due to the structure of the payments and a loss of developmental control.  SRS Life Sciences estimates that at launch, only 36% of milestone events have been achieved and only 30% of milestone payments have been paid.  In this type of evolving deal making environment, what are the key success factors for both sides to consider? Click here for for online registration and meeting information You are receiving this message because we believe you may be interested in the events and activities of the Licensing Executives Society. Our mailing address is: Licensing Executives Society 1800 Diagonal Road Suite 280 Alexandria, VA 22314 Copyright (C) 2012 Licensing Executives Society All rights reserved.

Sent to seth.t.chase@gmail.com — why did I get this? unsubscribe from this list | update subscription preferences Licensing Executives Society · 1800 Diagonal Road · Suite 280 · Alexandria, VA 22314

Can't Attend in Person? Now We Can Bring the Meeting to You!

Having trouble viewing this email? Click here

Don't let travel and budget constraints stop you from taking part in this must-attend event. Now you can access more of the LES Annual Meeting virtually than ever before!   For those unable to join us in Toronto, we're excited to announce our new virtual meeting option, where we'll bring the meeting to you wherever you are - on your computer or select mobile devices. Be a part of the interactive conversation through our live streaming sessions and access over 30 hours of on-demand content. You'll have access to: Live streaming access to five plenary sessions On-demand recording access to five plenary sessions, four mini-plenary sessions, and 16 of our most popular workshops Earn up to 6 CLE and CLP hours for attending the live broadcasts! All this for only $295 for LES members, and $395 for non-members.  Register online here     Live Streaming of our Special Keynote & Featured Sessions   Monday, October 15 9:00 am – 10:00 am: Keynote Speaker Connecting & Collaborating: The Convergence of Life Sciences and High Tech Dr. Eric J. Topol, Director, Scripps Translational Science Institute 1:00 pm – 2:00 pm:  Luncheon Speaker The Role of IP in Rebuilding Economies Following the Arab Spring Alaya Bettaieb, Secretary of State of Investment & International Cooperation of Tunisia Tuesday, October 16 9:00 am – 10:15 am: Plenary Session Is High Tech Crazy? Are We Experiencing a Patent Bubble?  Moderator: Chuck Neuenschwander, Principal, International Patent Licensing Co. Panelists:  Joe Dillon, Managing Director, Investor Relations and Business Development, Biotechnology Industry Organization (BIO), Dooyong Lee, CEO, Acacia, Joff Wild, Editor, IAM Magazine 10:45 am - 12:00 pm:  New Crowd-Sourcing Session Carving Out Your Commercial Space - Strategies and Trade Offs  Facilitators:  Kathleen Denis, Associate VP, Office of Technology Transfer, The Rockefeller University and Richard Razgaitis, Senior Advisor, Charles River Associates Wednesday, October 17 9:00 am – 10:30 am: Plenary Session Benches Unleashed: Judicial Views on Fixing the Systems Moderator: Brian P. O'Shaughnessy, Shareholder, Buchanan Ingersoll & Rooney Speakers:  Honourable Judge Roger Hughes, Federal Court of Canada and Honorable Paul Michel, Retired Chief Judge, United States Court of Appeals for the Federal Circuit  On-Demand Recordings of the Most Popular Sessions at the Meeting Chemicals, Energy, Environmental & Materials Mini-Plenary: Who's Funding Energy Investments in the Private Sector, and What's IP's Role in Securing It? High Tech Mini-Plenary: Cross-Border IP Transactions: What You Don't Know Can Hurt You Industry-University-Government Interface Mini-Plenary: Connecting & Creating: The Convergence of Industry, University and Government Collaborations Life Sciences Mini-Plenary: 2012 Life Sciences Royalty Rates & Deal Terms Survey – Results and Discussion with Deal Experts Plus on-demand access to 16 of our most popular workshops! View the workshop listings here. Register online here     Gold Sponsors    Silver Sponsors   Bronze Sponsors   Event Sponsors     Networking Reception Life Science Reception CEEM/IUGI Reception (partial) LESI Delegates Reception Lunch Sponsor LS Dinner & HTS Second City Event     Media Partners & Supporting Organizations Official Strategic Media Partner

© Licensing Executives Society (U.S.A. & Canada), Inc.

Forward email This email was sent to seth.t.chase@gmail.com by lesmeetings@les.org |   Update Profile/Email Address | Instant removal with SafeUnsubscribe™ | Privacy Policy. LES (USA & Canada) | 1800 Diagonal Road | Suite 280 | Alexandria | VA | 22314